RAFAEL HOLDINGS, INC. Proceeds from Sale of Buildings
RAFAEL HOLDINGS, INC. (RFL) reported Proceeds from Sale of Buildings of $3.66 million for the 12-month period ending 2021-07-31, per its 10-K filed 2022-10-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfBuildings · last filed 2022-10-31
- RAFAEL HOLDINGS, INC. proceeds from sale of buildings for fiscal 2021 was $3.66M.
| Period end | Proceeds from Sale of Buildings 12 month |
|---|---|
| 2021-07-31 | $3.66M 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |